These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19033530)

  • 1. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.
    Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults.
    Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G377-84. PubMed ID: 21596994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
    Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Busciglio I; Burton D; Baxter K; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G137-45. PubMed ID: 17395895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.
    Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR
    Dig Liver Dis; 2014 Feb; 46(2):113-8. PubMed ID: 24095618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
    Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans.
    Viramontes BE; Malcolm A; Camilleri M; Szarka LA; McKinzie S; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1468-76. PubMed ID: 11705752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans.
    Odunsi ST; Camilleri M; Bharucha AE; Papathanasopoulos A; Busciglio I; Burton D; Zinsmeister AR
    Dig Dis Sci; 2010 Mar; 55(3):709-15. PubMed ID: 19291400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
    Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
    Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.
    Acosta A; Camilleri M; Busciglio I; Boldingh A; Nelson AD; Burton D
    Dig Dis Sci; 2016 Mar; 61(3):852-60. PubMed ID: 26467700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic modulation of human colonic motor and sensory function.
    Bharucha AE; Camilleri M; Zinsmeister AR; Hanson RB
    Am J Physiol; 1997 Nov; 273(5):G997-1006. PubMed ID: 9374695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.
    Johanson JF; Ueno R
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1351-61. PubMed ID: 17509103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.
    Wong BS; Camilleri M; Busciglio I; Carlson P; Szarka LA; Burton D; Zinsmeister AR
    Gastroenterology; 2011 Nov; 141(5):1638-47.e1-7. PubMed ID: 21803011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High body mass alters colonic sensory-motor function and transit in humans.
    Delgado-Aros S; Camilleri M; Garcia MA; Burton D; Busciglio I
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G382-8. PubMed ID: 18617555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study.
    Hooks SB; Rutland TJ; Di Palma JA
    Gastrointest Endosc; 2009 Nov; 70(5):942-6. PubMed ID: 19577749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.
    Lacy BE; Chey WD
    Expert Opin Pharmacother; 2009 Jan; 10(1):143-52. PubMed ID: 19236188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans.
    Law NM; Bharucha AE; Undale AS; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2001 Nov; 281(5):G1228-37. PubMed ID: 11668032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variation of colonic motor functions in chronic constipation.
    Ravi K; Bharucha AE; Camilleri M; Rhoten D; Bakken T; Zinsmeister AR
    Gastroenterology; 2010 Jan; 138(1):89-97. PubMed ID: 19660461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome.
    Whitehead WE; Palsson OS; Gangarosa L; Turner M; Tucker J
    Neurogastroenterol Motil; 2011 Oct; 23(10):944-e400. PubMed ID: 21914041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.